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Background: The uncoupling proteins (UCPs) in the mitochondrial inner membrane are members of the
mitochondrial anion carrier protein family that play an important role in energy homeostasis. Genetic association
studies have shown that human UCP2 and UCP3 variants (SNPs and indels) are associated with obesity, insulin
resistance, type 2 diabetes mellitus, and metabolic syndrome. The aim of this study was to examine the genetic
association between polymorphisms in UCP2 and UCP3 and metabolic data in dogs.
Results: We identified 10 SNPs (9 intronic and 1 exonic) and 4 indels (intronic) in UCP2, and 13 SNPs (11 intronic
and 2 exonic) and one indel (exonic) in UCP3, by DNA sequence analysis of 11 different dog breeds (n = 119). An
association study between these UCP2 and UCP3 variants and the biochemical parameters of glucose, total
cholesterol, lactate dehydrogenase and triglyceride in Labrador Retrievers (n = 50) showed that none of the UCP2
polymorphisms were significantly associated with the levels of these parameters. However, four UCP3 SNPs (intron
1) were significantly associated with total cholesterol levels. In addition, the allele frequencies of two of the four
SNPs associated with higher total cholesterol levels in a breed that is susceptible to hypercholesterolemia (Shetland
Sheepdogs, n = 30), compared with the control breed (Shiba, n = 30).
Conclusion: The results obtained from a limited number of individuals suggest that the UCP3 gene in dogs may be
associated with total cholesterol levels. The examination of larger sample sizes and further analysis will lead to
increased precision of these results.
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The uncoupling proteins (UCPs) in the mitochondrial
inner membrane are members of the mitochondrial
anion carrier protein family [1,2]. Mammals have five
UCP homologs, of which UCP1, UCP2, and UCP3 are
closely related, while UCP4 and UCP5 are more diver-
gent from the other UCPs [3].
Based on genetic association studies, UCP2, UCP3, or
both are reportedly associated with obesity, insulin re-
sistance, type 2 diabetes mellitus, and metabolic syn-
drome in humans [4-11]. For example, a SNP in the 5′* Correspondence: t.omi@nvlu.ac.jp
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unless otherwise stated.untranslated region in human UCP3, the UCP3 -55CT
SNP, is known to be a genetic marker associated with
mRNA expression [12], elevated high density lipoprotein
cholesterol levels, a reduced body mass index (BMI),
weight, waist circumference, waist to hip ratio, fat mass,
low density lipoprotein (LDL) cholesterol, and total
cholesterol (T-Cho) [13-15].
The treatment and prevention of obesity and metabolic-
related diseases are also clinically important in dogs
[16-25]. Our previous report showed that the nucleotide
sequences, predicted amino acid sequences and the gen-
omic structures of human UCP2 and UCP3 are highly
homologous to the canine orthologs [26,27]. In this study,
we investigate whether the dog UCP2 and UCP3 genes
are associated with alterations in metabolism.ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 shows a schematic representation of the canine
UCP2 and UCP3 genes and the identified DNA poly-
morphisms from 119 animals from 11 breeds. For ana-
lysis of the dog UCP2 gene, six regions were individually
amplified from genomic DNA and sequenced. We then
identified 10 SNPs (9 intronic and 1 exonic) and 4 indels
(intronic) in UCP2 (Figure 1, Additional file 1). In the
dog UCP3 gene, 13 SNPs (11 intronic and 2 exonic) and
1 indel (exonic) were revealed by sequencing nine re-
gions of this gene (Figure 1, Additional file 1).
To test the association between the dog UCP2 and
UCP3 genes and metabolic data, we determined the
genotype of 50 Labrador Retrievers for each of 14 poly-
morphic sites (10 SNPs and 4 indels) in the UCP2 gene,
and examined whether any of the genotypes were associ-
ated with biochemical measurements of glucose (GLU),
total cholesterol (T-Cho), lactate dehydrogenase (LDH),
or triglyceride (TG). To exclude any contamination by
disease of the animals, we selected Labrador Retrievers
that had undergone a health examination for breeding
for guide dogs by the Kyushu Guide Dog Association.
The average of measurements was calculated with re-
spect to the genotype group. Nine of the 14 loci in the
UCP2 gene were polymorphic in this population of Lab-
rador Retrievers. None of these DNA polymorphisms in
the UCP2 gene were significantly associated with any of
the biochemical parameters in this study (Additional
file 2). We also subjected the 14 polymorphic sites (13
SNPs and 1 indel) in the UCP3 gene to this associationFigure 1 Schematic representation of the DNA polymorphisms detect
▬: Intron│: SNP or INDEL : PCR Fragment. The position of identified
methionine ATG codon as the +1 revealed in exon. In case of intron, a pos
previous exon, while a negative number indicates the number of nucleotidanalysis. Ten of the 14 sites were polymorphic in this
population of Labrador Retrievers. There were no sig-
nificant differences between genotype and GLU, LDH, or
TG measurements for any polymorphic site. However,
the T-Cho levels differed significantly among the geno-
type groups at four sites: −4399C/T, −4339T/C, −930T/
C and -803C/T in intron 1 of the UCP3 gene (UCP 3 in-
tron1). The average T-Cho levels in dogs carrying CC or
CT at -4399 C/T were 273.5 ± 49.0 and 237.2 ± 53.3, re-
spectively. The average T-Cho levels for the TT, TC, or
CC genotypes at -4339T/C and -930T/C were 264.3 ±
49.6, 276.9 ± 49.5, and 233.5 ± 51.2, respectively. Those
for CC or CT at -803C/T were 271.6 ± 49.5 and 239.1 ±
54.5, respectively (Table 1). The genotype distributions
were in a Hardy–Weinberg equilibrium.
Shetland Sheepdogs are considered to have a predis-
position to primary hyperlipidemia as determined by the
levels of cholesterol, triglycerides, and free fatty acids
[28,29]. Therefore, we investigated the distribution of ge-
notypes for SNPs and indels of the UCP2 and UCP3
genes in a population of Shetland Sheepdogs (n = 30).
Shiba (n = 30) were also tested as a comparative contrast
breed in this study. Statistically significant differences in
allele frequency between the two breeds were found in five
of the 14 polymorphic sites in UCP2 (−3629C/G, −2931A/
T, −748G/A, −636A/G and IVS6-133delTCTCCCC,
Additional file 3). Four SNPs (−4339T/C, −930T/C,
143A/C and IVS3+121T/C) of the 14 UCP3 poly-
morphic sites were significantly different in allele fre-
quency between the two breeds (Table 2). Despite theed in the UCP2 and UCP3 genes in dog. □: Exon(UTR) ■: Exon(CDS)
DNA polymorphism was numbered from the A of the initiator
itive number indicates the number of nucleotides away from the
e away from the next exon.
Table 1 Association analysis of UCP3 DNA polymorphisms with biochemical parameters among healthy Labrador
Retrievers
DNA polymorphism Genotype GLU T-Cho LDH TG
UCP3 CC (34) 97.1 ± 8.4 273.5 ± 49.0 55.9 ± 18.0 44.8 ± 21.1
−4399C/T CT (16) 98.8 ± 14.5 237.2 ± 53.3 55.7 ± 13.5 49.4 ± 24.8
TT (0) - - - -
CC vs CT + TT 0.597 0.021* 0.965 0.504
UCP3 TT (8) 94.5 ± 5.4 264.3 ± 49.6 55.3 ± 13.7 40.0 ± 13.5
−4339T/C TC (27) 96.3 ± 11.5 276.9 ± 49.5 58.2 ± 20.9 50.4 ± 24.8
CC (15) 101.7 ± 10.4 233.5 ± 51.2 51.9 ± 5.3 42.3 ± 20.5
TT vs TC + CC 0.366 0.890 0.914 0.388
TT + TC vs CC 0.079 0.011* 0.279 0.408
UCP3 CC (15) 94.4 ± 11.9 255.5 ± 52.6 56.9 ± 16.1 51.2 ± 23.2
−4010C/T CT (29) 98.7 ± 10.2 270.2 ± 52.2 56.5 ± 18.5 43.2 ± 21.5
TT (6) 100.7 ± 8.6 237.7 ± 54.7 50.0 ± 0.0 48.7 ± 24.6
CC vs CT + TT 0.159 0.580 0.763 0.310
CC + CT vs TT 0.462 0.234 0.362 0.782
UCP3 TT (8) 94.5 ± 5.4 264.3 ± 49.6 55.3 ± 13.7 40.0 ± 13.5
−930T/C TC (27) 96.3 ± 11.5 276.9 ± 49.5 58.2 ± 20.9 50.4 ± 24.8
CC (15) 101.7 ± 10.4 233.5 ± 51.2 51.9 ± 5.3 42.3 ± 20.5
TT vs TC + CC 0.366 0.890 0.914 0.388
TT + TC vs CC 0.079 0.011* 0.279 0.408
UCP3 CC (35) 96.9 ± 8.4 271.6 ± 49.5 55.7 ± 17.7 44.5 ± 20.9
−803C/T CT (15) 99.5 ± 14.8 239.1 ± 54.5 56.1 ± 13.9 50.5 ± 25.2
TT (0) - - - -
CC vs CT + TT 0.431 0.045* 0.950 0.388
UCP3 TT (15) 94.4 ± 11.9 255.5 ± 52.6 56.9 ± 16.1 51.2 ± 23.2
IVS3+26T/C TC (29) 98.7 ± 10.2 270.2 ± 52.2 56.5 ± 18.5 43.2 ± 21.5
CC (6) 100.7 ± 8.6 237.7 ± 54.7 50.0 ± 0.0 48.7 ± 24.6
TT vs TC + CC 0.159 0.580 0.763 0.310
TT + TC vs CC 0.462 0.234 0.362 0.782
UCP3 GG (15) 94.4 ± 11.9 255.5 ± 52.6 56.9 ± 16.1 51.2 ± 23.2
IVS3+69G/A GA (29) 98.7 ± 10.2 270.2 ± 52.2 56.5 ± 18.5 43.2 ± 21.5
AA (6) 100.7 ± 8.6 237.7 ± 54.7 50.0 ± 0.0 48.7 ± 24.6
GG vs GA + AA 0.159 0.580 0.763 0.310
GG + GA vs AA 0.462 0.234 0.362 0.782
UCP3 GG (15) 94.4 ± 11.9 255.5 ± 52.6 56.9 ± 16.1 51.2 ± 23.2
IVS5-115G/C GC (29) 98.7 ± 10.2 270.2 ± 52.2 56.5 ± 18.5 43.2 ± 21.5
CC (6) 100.7 ± 8.6 237.7 ± 54.7 50.0 ± 0.0 48.7 ± 24.6
GG vs GC + CC 0.159 0.580 0.763 0.310
GG + GC vs CC 0.462 0.234 0.362 0.782
UCP3 TT (15) 94.4 ± 11.9 255.5 ± 52.6 56.9 ± 16.1 51.2 ± 23.2
IVS5-100T/C TC (29) 98.7 ± 10.2 270.2 ± 52.2 56.5 ± 18.5 43.2 ± 21.5
CC (6) 100.7 ± 8.6 237.7 ± 54.7 50.0 ± 0.0 48.7 ± 24.6
TT vs TC + CC 0.159 0.580 0.763 0.310
TT + TC vs CC 0.462 0.234 0.362 0.782
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Table 1 Association analysis of UCP3 DNA polymorphisms with biochemical parameters among healthy Labrador
Retrievers (Continued)
UCP3 II (15) 94.4 ± 11.9 255.5 ± 52.6 56.9 ± 16.1 51.2 ± 23.2
1106delAAG ID (29) 98.7 ± 10.2 270.2 ± 52.2 56.5 ± 18.5 43.2 ± 21.5
DD (6) 100.7 ± 8.6 237.7 ± 54.7 50.0 ± 0.0 48.7 ± 24.6
II vs ID + DD 0.159 0.580 0.763 0.310
II + ID vs DD 0.462 0.234 0.362 0.782
Data are expressed as the mean ± SD.
p-values were calculated by ANOVA. * and bold: p < 0.05.
I: insertion, D: deletion, IVS: intervening sequence.
Loci which were not observed polymorphism in Labrador retriever, or were not detected p-value are not shown.
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[30-32], the different allele frequencies in the UCP2
and UCP3 polymorphic site between the two breeds
may result from the susceptibility of Shetland Sheep-
dogs to hypercholesterolemia in a limited number of
individuals.
The T allele at -4339T/C and -930T/C located in the
UCP3 intron 1 is associated with higher T-Cho levels, as
shown by two different experiments: the association be-
tween polymorphisms and metabolic data (Table 1), and
the distribution of allele of genotype in the breed that is
susceptible to hypercholesterolemia (Table 2). These re-
sults suggest that the dog UCP3 gene might be associated
with T-Cho levels in a limited number of individuals.
It is known that the peroxisome proliferator activated
receptors (PPAR) ligands activate UCP3 expression
[33,34]. The UCP3 intron 1 contains that the putative
binding elements of MyoG/MyoD, PPARγ/RXRα and
SP1/SP3 that enhanced the UCP3 gene transcription
mainly regulated by PPARs in hamster, rat, and mouse
[33]. Recently, we find the similar nucleotide sequences
of the PPARγ/RXRα element in the dog UCP3 intron 1
(Canine Genome Draft, NC_006603.3). These findings
imply that the dog UCP3 intron 1 may be associated
with regulation of UCP3 gene expression. Further stud-
ies will be needed to demonstrate whether PPAR li-
gands bind or not this intronic region in dog.
With each genetic study, a different sample size is used
to identify the candidate gene associating with genotypes
and phenotypes in common diseases (multifactorial dis-
eases) and/or single gene disorders. For instance, genome-
wide association studies (GWAS) have reported the
candidate gene associated with a mild form of dispro-
portionate dwarfism using 23 cases and 37 controls
[35], atopic dermatitis using 91 cases and 88 controls
[36], and the chromosomal region of Patellar Luxation
using 45 cases and 40 controls [37]. Some of the candi-
date genes were also tested using more than a hundred
samples. The examination of larger sample sizes and
further analysis will lead to increased precision of ourresults. In addition, because the association analysis in
this study was performed using only polymorphisms
within the UCP2 and UCP3 genes, we cannot exclude
the possibility that a gene that is closely linked to
UCP3 is causal.
Conclusions
A genetic association study between polymorphisms in
the dog uncoupling protein 2 and 3 genes and metabolic
data showed that the SNPs of the UCP3 intron 1 were
associated with T-Cho levels in Labrador Retrievers. Al-
leles associated with high T-Cho levels of these polymor-
phisms were also present at higher frequencies in a
breed that is susceptible to hypercholesterolemia (Shet-
land Sheepdogs), than in the control group (Shiba). The
results obtained from a limited number of individuals
suggest that the UCP3 gene in dogs may be associated
with total cholesterol levels. Therefore, the UCP3 gene
could be an interesting target, not only for lipid metab-
olism, but also for the treatment and prevention of obes-
ity and metabolic-related diseases in dogs.
Methods
Animals and DNA
All animal experiments were approved by The Experimen-
tal Animal Ethics Committee in Nippon Veterinary and
Life Science University. The blood samples were originally
collected at the Veterinary Medical Teaching Hospital at
NVLU with the written consent of each owner or the
Kyushu Guide Dog Association. The collection of sam-
ples was handled by licensed veterinarians only.
Panel 1, for the first SNP discovery, was collected from
11 dogs that represented 11 different breeds: Miniature
Dachshund, Welsh Corgi, Labrador Retriever, Shetland
Sheepdog, Beagle, Yorkshire Terrier, Dobermann, Whip-
pet, Weimaraner, Papillon, and Shiba. Panel 2 was used
for SNP discovery and a study of associations between
SNP variants and biochemical parameters; these samples
were collected from 50 Labrador Retrievers. Panel 3 was
used for SNP discovery and an interbreed analysis was
Table 2 Genotyping data and interbreed analysis of DNA polymorphisms in UCP3
UCP3 DNA
polymorphism
Genotype Number of samples
p Allele
Allele frequency
Shiba Shetland sheepdog Shiba Shetland sheepdog
−4399C/T CC 29 30 NS C 0.98 1.00
CT 1 0 CC vs CT + TT T 0.02 0.00
TT 0 0
−4339T/C TT 0 4 p < 0.05 T 0.07 0.37
TC 4 14 TT + TC vs CC C 0.93 0.63
CC 26 12
−4160G/A GG 30 30
ND
G 1.00 1.00
GA 0 0 A 0.00 0.00
AA 0 0
−4010C/T CC 18 13 NS C 0.75 0.70
CT 9 16
CC vs CT + TT
T 0.25 0.30
TT 3 1
−930T/C TT 0 4 p < 0.05 T 0.07 0.37
TC 4 14 TT + TC vs CC C 0.93 0.63
CC 26 12
−803C/T CC 30 30
ND
C 1.00 1.00
CT 0 0 T 0.00 0.00
TT 0 0
143A/C AA 20 30 p < 0.05 A 0.82 1.00
AC 9 0 AA vs AC + CC C 0.18 0.00
CC 1 0
IVS3+26T/C TT 10 13 NS T 0.57 0.70
TC 14 16 TT vs TC + CC C 0.43 0.30
CC 6 1
IVS3+69G/A GG 18 13 NS G 0.75 0.70
GA 9 16 GG vs GA + AA A 0.25 0.30
AA 3 1
IVS3+121T/C TT 29 14 p < 0.05 T 0.98 0.67
TC 1 12 TT vs TC + CC C 0.02 0.33
CC 0 4
IVS5-115G/C GG 10 4 NS G 0.55 0.37
GC 13 14 GG + GC vs CC C 0.45 0.63
CC 7 12
IVS5-100T/C TT 18 13 NS T 0.75 0.70
TC 9 16 TT vs TC + CC C 0.25 0.30
CC 3 1
838T/C TT 28 30 NS T 0.97 1.00
TC 2 0 TT vs TC + CC C 0.03 0.00
CC 0 0
1106delAAG ins ins 18 13 NS ins 0.75 0.70
ins del 9 16 II vs ID + DD del 0.25 0.30
del del 3 1
I: insertion, D: deletion. IVS: intervening sequence.
p-values were calculated by Fisher’s exact test. p < 0.05 NS:not significance. ND: not detection.
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containing each one animals from Panel 1. A list of breeds
and number of individuals are presented in Table 3. Gen-
omic DNA was extracted from whole blood with the
Puregene kit (Qiagen, Valencia CA, USA).PCR
We used sequences of UCP2 and UCP3 (Canine Gen-
ome Draft, NC_006603.3), to design 15 pairs of primers
for amplification of each exon of the UCP2 and UCP3
genes (Table 4). Each PCR using TaKaRa Ex Taq was
performed in a total volume of 25 μl and contained
20 ng genomic DNA, 2.5 μl 10× Ex Taq Buffer (including
20 mM Tris–HCl, 100 mM KCl, 0.1 mM EDTA, 1 mM
DTT, 0.5% Tween 20, 0.5% Nonidet P-40, 50% Glycerol,
20 mM Mg2+), 0.4 mM of each primer, 200 μM dNTP
(dATP, dTTP, dCTP and dGTP), and 1U TaKaRa Ex Taq
(TaKaRa, Shiga, Japan). Each PCR using FastStart Taq
DNA polymerase (Roche, Basel, Switzerland)) was per-
formed in a total volume of 25 μl and contained 20 ng
genomic DNA, 2.5 μl 10× reaction Buffer (including
500 mM Tris–HCl, 100 mM KCl, 50 mM (NH4)2SO4,
20 mM MgCl2), 0.4 mM of each primer (F12: 0.2 mM
of each primer), 200 μM dNTP (dATP, dTTP, dCTP





Panel 1a Miniature Dachshund 1 1
Welsh Corgi 1 1
Labrador Retriever 1 1
Shetland Sheepdog 1 1
Beagle 1 1






Panel 2a,b,d Labrador Retriever 50 27 23
Panel 3a,b,c Shetland Sheepdog 30e 15 15
Shiba 30e 15 15
Total 119f 60 59




d. Association analysis of DNA polymorphisms with biochemical parameters.
e. Include one individual of panel 1.
f. Total numbers of independent individuals.necessary, we used FastStart Taq for primer pairs that
did not work with TaKaRa Ex Taq. The PCR reactions
were performed on TaKaRa PCR Thermal Cycler Dice
TP600 (TaKaRa). The conditions for PCR are shown in
Table 5.Sequencing and SNP detection
The PCR products were purified with High Pure PCR
Product Purification Kit (Roche). Cycle sequencing was
then performed with the Big Dye Terminator v3.1 kit (Ap-
plied Biosystems, Foster City CA, USA); each reaction was
run in a 10 μl reaction volume containing 1 μl purified
PCR amplification product, 1 μl Ready Reaction Premix,
1.5 μl 5× Big Dye Sequence Buffer, 1 μl primer (1.6
pmol/μl), and 5.5 μl sterile water. Cycle sequencing reac-
tions were performed with the following conditions: 60 s
at 96°C followed by 25 cycles of 10 s at 96°C, 5 s at 50°C
and 4 min at 60°C. BigDye Xterminator Purification kits
were used according to the manufacturer’s instructions
(Applied Biosystems) to purify dye-labeled fragments. Sam-
ples were analyzed on an ABI PRISM 310 genetic analyzer
(Applied Biosystems). We identified DNA polymorphisms
by comparing each sequence with the reference sequence
(Canine Genome Draft. NC_006603.3) by BLAST in NCBI
(National Center for Biotechnology Information) and
GENETYX program Ver. 11(GENETYX Corporation,
Tokyo, Japan). The position of identified DNA polymorph-
ism was numbered from the A of the initiator methionine
ATG codon as the +1 revealed in exon. In case of in-
tron, a positive number indicates the number of nucle-
otides away from the previous exon, while a negative
number indicates the number of nucleotide away from
the next exon.Measurement of biochemical parameters
Blood samples were collected into heparinized plastic
tubes at least 12 h postprandial. Plasma was separated
by centrifugation at 1500× g for 10 min. Glucose (GLU),
triglyceride (TG), total cholesterol (T-Cho), and lactate
dehydrogenase (LDH) were measured using a Spotchem
EM SP-4430 (Arkray, Kyoto, Japan) with the manufac-
turer’s reagents.Statistical analysis
Deviation from the Hardy–Weinberg equilibrium was
assessed by the Chi-squared test. SNPAlyze (Dynacom,
Chiba, Japan) was used to estimate haplotype frequen-
cies. Genotype frequencies were compared using the
Fisher’s exact test. Differences of p < 0.05 were consid-
ered statistically significant. Associations between geno-
type frequencies and metabolic data were analyzed by
one-way analysis of variance (ANOVA).
Table 4 Sequences of primers for PCR















































































Intron 6, Exon 7
UCP3F15-R TTCAGCCTTTCCTGTACACA
a. Number of nucleotide position is from canine genome draft (CGD) NC_006603.3.
b. Fl: Flanking region Start codon is located in Exon 3 in UCP2 and Exon 2 in UCP3. Stop codon is located in Exon 8 in UCP2 and Exon 7 in UCP3.
Udagawa et al. BMC Research Notes 2014, 7:904 Page 7 of 9
http://www.biomedcentral.com/1756-0500/7/904Additional files
Additional file 1: Description and localization of identified DNA
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Table 5 Conditions for PCR
Fragment Taqa Initial denature (°C/m)b Denature (°C/m)b Annealing (°C/s)b Extention (°C/m)b Cycle Final extention (°C/m)b
F1 F 95/4 95/1 57/30 72/1 35 72/7
F2 E 95/1 95/1 60/30 72/1 35 72/7
F3 F 95/4 95/1 60/10 72/1 30 72/7
F4 E 95/1 95/1 60/30 72/1 35 72/7
F5 F 95/4 95/1 60/30 72/1 35 72/7
F6 E 95/1 95/1 62/30 72/1 35 72/7
F7 E 95/1 95/1 60/15 72/1 34 72/7
F8 F 95/4 95/1 62/30 72/1 35 72/7
F9 F 95/4 95/1 62/30 72/1 35 72/7
F10 E 95/1 95/1 60/30 72/1 35 72/7
F11 F 95/4 95/1 62/15 72/1 32 72/7
F12 E 95/1 95/1 60/30 72/1 35 72/7
F13 E 95/1 95/1 60/30 72/1 35 72/7
F14 E 95/1 95/1 60/30 72/1 35 72/7
F15 E 95/1 95/1 60/30 72/1 35 72/7
a. Taq polymerase: E = ExTaq (TaKaRa), F = Fast start Taq (Roche).
b. m: minutes s: seconds.
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